Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults ...

COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

Cause, Potential Treatments ID'd for Persistent COVID-19 Lung Problems Sep. 5, 2024 — Arthritis drugs already available for prescription have the potential to halt lingering lung problems that ...

The following is a summary of “Clinical and ultrasound characteristics in patients with sars-cov-2 pneumonia, associated with ...

Posts have flooded social media warning that a new pandemic could be starting in China. Here's why scientists think those ...

The recent HMPV surge in China has raised concerns about another pandemic. While there are debates about its similarities ...

Five years after the COVID-19 pandemic began, millions who are considered immunocompromised still avoid crowds and even ...

Staying healthy in the New Year presents a new challenge for Americans who are coping with what health officials are calling a “ quad-demic ,” which involves a quartet of infectious viruses that are ...

Practical tips to protect your health during wildfire season, including wearing masks, staying indoors, and tracking air ...

Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.